4.7 Article

Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma

Related references

Note: Only part of the references are listed.
Review Anatomy & Morphology

Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target

Sven Jonckheere et al.

Summary: Metastasis, the spread of cancer cells to distant sites, is the primary cause of cancer morbidity and mortality. During the initial stages of metastasis, cancer cells undergo EMT, becoming migratory and invasive mesenchymal-like cells with stem cell properties. Targeting EMT in therapy has the potential to prevent cancer cell invasion and dissemination, reduce cancer stemness, and enhance the effectiveness of chemotherapy.

CELLS TISSUES ORGANS (2022)

Article Medicine, General & Internal

DEK overexpression is predictive of poor prognosis in esophageal squamous cell carcinoma

Huochun Yi et al.

Summary: DEK protein is overexpressed in ESCC tissues, associated with poor prognosis, and can independently predict the prognosis of ESCC patients.

ARCHIVES OF MEDICAL SCIENCE (2021)

Article Pharmacology & Pharmacy

Atractylodin inhibited the migration and induced autophagy in cholangiocarcinoma cells via PI3K/AKT/mTOR and p38MAPK signalling pathways

Bishwanath Acharya et al.

Summary: Atractylodin inhibits proliferation and induces autophagy in cholangiocarcinoma cells by regulating the PI3K/AKT/mTOR and p38MAPK signaling pathways.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2021)

Article Oncology

DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression

Mai-Qing Yang et al.

Summary: DEK expression is significantly increased in breast cancer tissues, and high DEK expression is associated with aggressive tumor features and poor prognosis. Overexpression of DEK promotes the proliferative and invasive abilities of breast cancer cells.

ONCOLOGY LETTERS (2021)

Review Oncology

Targeting Akt in cancer for precision therapy

Hui Hua et al.

Summary: Biomarkers-guided precision therapeutics has revolutionized the clinical development and administration of molecular-targeted anticancer agents. Tailored precision cancer therapy exhibits better response rate compared to unselective treatment. Protein kinases have critical roles in cell signaling, metabolism, proliferation, survival and migration. Aberrant activation of protein kinases is critical for tumor growth and progression. Consequently, protein kinases are key targets for molecular targeted cancer therapy. The serine/threonine kinase Akt is frequently activated in various types of cancer. Activation of Akt promotes tumor progression and drug resistance. Since the first Akt inhibitor was reported in 2000, many Akt inhibitors have been developed and evaluated in either early or late stage of clinical trials, which take advantage of liquid biopsy and genomic or molecular profiling to realize personalized cancer therapy. Two inhibitors, capivasertib and ipatasertib, are being tested in phase III clinical trials for cancer therapy. This article highlights recent progress of Akt signaling pathway, reviews the up-to-date data from clinical studies of Akt inhibitors and discusses the potential biomarkers that may help personalized treatment of cancer with Akt inhibitors. Additionally, it also discusses how Akt may confer the vulnerability of cancer cells to some kinds of anticancer agents.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Pharmacology & Pharmacy

Cordycepin Inhibits Cancer Cell Proliferation and Angiogenesis through a DEK Interaction via ERK Signaling in Cholangiocarcinoma

Tesi Liu et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)

Article Medicine, Research & Experimental

Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling

Maegan L. Capitano et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Biochemistry & Molecular Biology

Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process

Mostafa Karimi Roshan et al.

BIOCHIMIE (2019)

Review Oncology

Cholangiocarcinoma - evolving concepts and therapeutic strategies

Sumera Rizvi et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Oncology

The Complexity of DEK Signaling in Cancer Progression

Yong Teng et al.

CURRENT CANCER DRUG TARGETS (2018)

Review Oncology

PKB/Akt-dependent regulation of inflammation in cancer

Fengyuan Tang et al.

SEMINARS IN CANCER BIOLOGY (2018)

Article Agriculture, Multidisciplinary

Novel ent-Kaurane Diterpenoid from Rubus corchorifolius L. f. Inhibits Human Colon Cancer Cell Growth via Inducing Cell Cycle Arrest and Apoptosis

Xuexiang Chen et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)

Review Oncology

New Horizons for Precision Medicine in Biliary Tract Cancers

Juan W. Valle et al.

CANCER DISCOVERY (2017)

Article Cell Biology

Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?

Maren Diepenbruck et al.

CURRENT OPINION IN CELL BIOLOGY (2016)

Review Biochemistry & Molecular Biology

Black Crowberry (Empetrum nigrum L.) Flavonoids and Their Health Promoting Activity

Tunde Jurikova et al.

MOLECULES (2016)

Article Pharmacology & Pharmacy

Dieckol Attenuates Microglia-mediated Neuronal Cell Death via ERK, Akt and NADPH Oxidase-mediated Pathways

Yanji Cui et al.

KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2015)

Article Biochemistry & Molecular Biology

Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer

Jiezhong Chen et al.

CURRENT MEDICINAL CHEMISTRY (2014)

Article Integrative & Complementary Medicine

Empetrum nigrum var. japonicum Extract Suppresses Ultraviolet B-Induced Cell Damage via Absorption of Radiation and Inhibition of Oxidative Stress

Ki Cheon Kim et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)

Article Pharmacology & Pharmacy

Thymoquinone: Potential cure for inflammatory disorders and cancer

Chern Chiuh Woo et al.

BIOCHEMICAL PHARMACOLOGY (2012)

Article Oncology

Control of Tumorigenesis and Chemoresistance by the DEK Oncogene

Erica Riveiro-Falkenbach et al.

CLINICAL CANCER RESEARCH (2010)

Article Agriculture, Multidisciplinary

Variation in the Anthocyanin Concentration of Wild Populations of Crowberries (Empetrum nigrum L subsp hermaphroditum)

Ali K. J. Koskela et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)

Review Biology

Progress in studies on the DEK protein and its involvement in cellular apoptosis

Hua Ying et al.

SCIENCE IN CHINA SERIES C-LIFE SCIENCES (2009)

Article Chemistry, Analytical

Simultaneous determination of flavonoids in Ixeridium gracile by micellar electrokinetic chromatography

Yu Zhang et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)

Article Biochemistry & Molecular Biology

Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia

C Hetz et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)